LICA PHARMACEUTICALS ApS: Financial statements 2013
CVR: 25332520
Source: annual report 2013, Danish Business Authority
01/01/2013 – 31/12/2013
LICA PHARMACEUTICALS ApS (CVR 25332520) has filed annual accounts for 2013. In 2013, the company reported a gross profit of DKK 341,415 and a net result of DKK 782,891 compared with DKK 953,184 the year before. That is an increase of 15.5% compared with the year before. Equity in the 2013 report amounted to DKK 10,041,017. The solvency ratio was 99.8%.
- Gross Profit
- DKK 341,415
- Profit/Loss
- DKK 782,891
- Equity
- DKK 10,041,017
- Total Assets
- DKK 10,057,211
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2013 | - | 341 t. | 783 t. | 10 mio. | - |
| 2012 | 468 t. | 296 t. | 953 t. | 9.3 mio. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2013
LICA PHARMACEUTICALS ApS has published its annual report for 2012. Revenue came to DKK 468,291, and the net result was DKK 953,184.
About LICA PHARMACEUTICALS ApS
LICA PHARMACEUTICALS ApS is a Danish company of the type Anpartsselskab based in Hellerup, founded in 2000. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named LICA PHARMACEUTICALS A/S. The company has 1 employee (2013). In 2025, the company reported a gross profit of DKK 359,449 and a net result of DKK 450,710 compared with DKK 1,406,816 the year before. Equity in the 2025 report amounted to DKK 24,221,286.